daraxonrasib
RMC-6236-303
Phase 3 small_molecule active
Quick answer
daraxonrasib for Pancreatic Cancer is a Phase 3 program (small_molecule) at Revolution Medicines with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Revolution Medicines
- Indication
- Pancreatic Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active